A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.

NCT00415311 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to terminate the study

Conditions

Liver Transplantation

Interventions

DRUG: Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)
DRUG: Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)
DRUG: Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)

Sponsor

Enzon Pharmaceuticals, Inc.